Combating Coronavirus
As the new virus spreads, more information is needed to mount an appropriate response.
Elsevier has created a free information center on coronavirus 2019-nCoV that compiles clinical research, including content from medical journals, textbooks, clinical experts, major health organizations and more (1). The information is available in both English and Mandarin.
At the moment, no specific antiviral agent is available for treating the virus and there is no vaccine. However, researchers have already posted a sequence of 2019-CoV in a public database and some companies and institutes are already looking for a vaccine, including Massachusetts biotech Moderna, which is working with the US’s National Institutes of Health, the National Institute of Allergy and Infectious Diseases, and the Vaccine Research Center (2).
As of January 29, WHO reported that 6065 confirmed 2019-nCoV cases have been reported globally – the majority in China – including 132 deaths (3).
- Elsevier, “Novel Coronavirus Information Center,” (2020). Available at https://bit.ly/2RVgbQ3.
- CNBC, “Biotech firm Moderna is working on a vaccine for China’s deadly coronavirus,” (2020). Available at cnb.cx/2RvFyce.
- WHO, “Novel Coronavirus(2019-nCoV) Situation Report – 9,” (2020). Available at bit.ly/2REyo5H.
Making great scientific magazines isn’t just about delivering knowledge and high quality content; it’s also about packaging these in the right words to ensure that someone is truly inspired by a topic. My passion is ensuring that our authors’ expertise is presented as a seamless and enjoyable reading experience, whether in print, in digital or on social media. I’ve spent fourteen years writing and editing features for scientific and manufacturing publications, and in making this content engaging and accessible without sacrificing its scientific integrity. There is nothing better than a magazine with great content that feels great to read.
